Jamie Gould, Consultant at The RSA Group, explores the talent landscape of the immuno-oncology sector. Immuno-oncology harnesses the power of the body’s immune system to fight cancer. This exciting field is rapidly evolving and already delivering a revolution in cancer therapeutics with a steady stream of recent approvals. In June… Read More
Despite December usually being a slower time for recruitment, there has been a high number of senior moves within the drug discovery sector over the last three months. Shorla Oncology has appointed Rayna Sethi Herman as Chief Commercial Officer. Herman leaves a role as CCO at… Read More
There have been a number of high-level career moves within the industry in the last couple of weeks. In this update, we provide a round-up of the latest senior appointments and promotions. Nick Maishman, ViroCell Biologics Nick Maishman has joined contract development and manufacturing organisation ViroCell as Chief Operating Officer. Read More
Life science company ValiRx has appointed Dr Cathy Tralau-Stewart as its interim Chief Scientific Officer (CSO) to help bolster its drug discovery and therapeutic expertise. Dr Tralau-Stewart has over 20 years’ senior academic and industry leadership experience and joins ValiRx from drug discovery company C4X Discovery. At C4X Discovery Dr… Read More
Albany College of Pharmacy and Health Sciences has an opening for the Director of The Stack Family Centre for Biopharmaceutical Education and Training (CBET). CBET is an evolutionary leap in health sciences education and biomanufacturing workforce training. The CBET Director will be responsible for the development and creation of sustainable… Read More
